https://www.selleckchem.com/pr....oducts/acss2-inhibit
High incidence of asymptomatic venous thromboembolism (VTE) has been observed in severe COVID-19 patients, but the characteristics of symptomatic VTE in general COVID-19 patients have not been described. To comprehensively explore the prevalence and reliable risk prediction for VTE in COVID-19 patients. This retrospective study enrolled all COVID-19 patients with a subsequent VTE in 16 centers in China from January 1 to March 31, 2020. A total of 2779 patients were confirmed with COVID-19. In comparison to 23,434 non-COVID-19 me
Like
Comment
Share
